Status:
UNKNOWN
Calibration of the Average Breathing Rate Measurement of the Cloud DX Pulsewave Health Monitor (PAD-2A) Device (CCV-3)
Lead Sponsor:
Cardiovascular Research New Brunswick
Collaborating Sponsors:
Cloud DX Inc.
Horizon Health Network
Conditions:
Outpatients
Eligibility:
All Genders
19+ years
Brief Summary
The purpose of this study is to calibrate the average breathing rate measurement of the PAD-2A device to be within ±2 breaths per minute of clinical capnography breathing rate measurements.
Detailed Description
The plan for this study is to calibrate the average breathing rate measurement of the PAD-2A device with the breathing rate measurement of a standard clinical capnography device. The data will be coll...
Eligibility Criteria
Inclusion
- Adults ≥ 19 years of age (minimum 30% male/female)
- Wrist circumference between 13.5cm - 23cm (5.3 in. - 9.1in.)
- Specifically for this test device, the wrist size of the consented participants will be distributed accordingly for a Gaussian distribution:
- Lowest Octile: ≥ 13.5cm to \< 14.7cm Lower Quarter: ≥ 13.5cm to \< 15.9cm Lower-Middle Quarter: ≥ 15.9cm to \< 18.3cm Upper-Middle Quarter: ≥ 18.3cm to \< 20.7cm Upper Quarter: ≥ 20.7cm to ≤ 23.0cm Highest Octile: ≥ 21.9cm to ≤ 23.0cm
- • Willing to volunteer to participate and to sign the study specific informed consent form
Exclusion
- Wrist circumference less than 13.5cm (5.3 in.) or greater than 23cm (9.1 in)
- Hand or body tremors
- Canadian Cardiovascular Society (CCS) grade III or IV angina pectoris (chest pain)
- Unexplained shortness of breath at rest
- History of seizures (except childhood febrile seizures)
- Epilepsy
- History of unexplained syncope (fainting)
- Pregnant
- A musculoskeletal disorder that prevents a non-invasive device to be inflated/deflated on the arm
- Unwilling to volunteer to participate and to sign the study specific informed consent form
Key Trial Info
Start Date :
September 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04868630
Start Date
September 10 2021
End Date
December 31 2023
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Horizon Health Network
Saint John, New Brunswick, Canada